Wallbox (NYSE: WBX) secures NYSE acceptance of plan to restore listing compliance
Rhea-AI Filing Summary
Wallbox N.V. reports that the NYSE has accepted its plan to regain compliance with the exchange’s continued listing standards. The company had been below Section 802.01B thresholds for average global market capitalization and total stockholders’ equity after a February 12, 2026 notice.
Wallbox now has an 18‑month cure period from that notice to reach either stockholders’ equity of at least $50 million or an average global market capitalization over a consecutive 30 trading‑day period of $50 million. During this period, its Class A ordinary shares will continue trading on the NYSE, subject to progress against the plan, semi‑annual NYSE reviews, and compliance with other listing requirements, including timely fee payments.
Positive
- None.
Negative
- NYSE noncompliance and delisting risk: Wallbox is currently below NYSE Section 802.01B thresholds and must reach at least $50 million in stockholders’ equity or average global market capitalization within an 18‑month cure period to avoid potential suspension or delisting of its Class A shares.
Insights
Wallbox remains noncompliant but secures time to fix NYSE listing issues.
Wallbox confirms the NYSE has accepted its remediation plan after falling below Section 802.01B thresholds for average global market capitalization and total stockholders’ equity. Acceptance means the exchange will allow continued trading while the company works to restore compliance.
The company has an 18‑month cure window from the February 12, 2026 notice to achieve either stockholders’ equity of at least $50 million or a 30‑day average global market cap of $50 million. Semi‑annual NYSE reviews and ongoing obligations, including timely listing and annual fees, create structured checkpoints and potential suspension or delisting risk if milestones are missed.
Management states that normal business operations are unaffected, and the firm will provide semi‑annual progress updates aligned with SEC filings. Actual impact for shareholders will depend on whether Wallbox can improve its financial position enough within the cure period to meet the NYSE thresholds and avoid any future listing actions.
Key Figures
Key Terms
continued listing standards regulatory
average global market capitalization financial
stockholders’ equity financial
cure period regulatory
forward-looking statements regulatory
FAQ
What did Wallbox (WBX) announce regarding its NYSE listing status?
Why was Wallbox (WBX) considered noncompliant with NYSE standards?
How long does Wallbox have to regain NYSE listing compliance?
What financial thresholds must Wallbox meet to satisfy NYSE requirements?
Does the NYSE compliance plan affect Wallbox’s normal business operations?
AI-generated analysis. How Rhea-AI works. Not financial advice.